• VentriPoint issued 601,115 common shares to settle $72,143 of accrued interest on outstanding Convertible Debentures.
• Debentures were issued on May 10, 2024, June 28, 2024, and Dec. 16, 2024; they carry 10% annual interest paid semiannually.
• Shares were issued at a deemed price of $0.12; securities are subject to a four-month-and-one-day hold.
• Insiders received 48,383 shares as part of the interest settlement; the transaction does not create a control person.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VentriPoint Diagnostics Ltd. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202609140800TNWSWRCACNPR_____1BR1FZMbD) on September 14, 2026, and is solely responsible for the information contained therein.